SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-098598
Filing Date
2012-03-06
Accepted
2012-03-06 13:42:03
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 20-F d279567d20f.htm 20-F 7348598
2 ARTICLES OF ASSOCIATION (STATUTS) OF SANOFI (ENGLISH TRANSLATION) d279567dex11.htm EX-1.1 42445
3 BOARD CHARTER (REGLEMENT INTERIEUR) OF SANOFI (ENGLISH TRANSLATION) d279567dex12.htm EX-1.2 68640
4 CERTIFICATION BY CHRISTOPHER VIEBACHER, CEO, REQUIRED BY SECTION 302 d279567dex121.htm EX-12.1 10437
5 CERTIFICATION BY JEROME CONTAMINE, PFO, REQUIRED BY SECTION 302 d279567dex122.htm EX-12.2 10437
6 CERTIFICATION BY CHRISTOPHER VIEBACHER, CEO REQUIRED BY SECTION 906 d279567dex131.htm EX-13.1 3951
7 CERTIFICATION BY JEROME CONTAMINE, PFO, REQUIRED BY SECTION 906 d279567dex132.htm EX-13.2 4088
8 CONSENT OF ERNST & YOUNG AUDIT d279567dex231.htm EX-23.1 2515
9 CONSENT OF PRICEWATERHOUSECOOPERS AUDIT d279567dex232.htm EX-23.2 1732
10 REPORT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR 2011 d279567dex991.htm EX-99.1 70450
  Complete submission text file 0001193125-12-098598.txt   7564424
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 12669665
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences